PhaseBio Pharmaceuticals, Inc. (PHAS)
Deferred Revenue
$1.40M
Quarterly · Period ending: · USD
PHAS Deferred Revenue
Latest reported$1.40Mperiod ending
Latest reported$1.40Mperiod ending
PHAS Quarterly Deferred Revenue ($0.00 → $1.40M)
Quarterly deferred revenue
High-resolution chart · PNG
PHAS deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 1,400,000 | |
| 1,594,000 | |
| 1,547,000 | |
| 1,414,000 | |
| 1,424,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |